Ensifentrine improves lung function in COPD patients
However, the company has decided to postpone the initiation of Part B due to concerns regarding the COVID-19 pandemic.
Read MoreHowever, the company has decided to postpone the initiation of Part B due to concerns regarding the COVID-19 pandemic.
Read MoreAcute coronary syndrome is a type of cardiovascular disease that occurs when a blood clot forms.
Read MoreVertex has also revealed its plans to keep clinical trials going during the unstable time.
Read MoreThe meeting was held virtually to help limit the spread of COVID-19.
Read MoreThe new data from the trial “further reinforce Forxiga’s clinical effects beyond diabetes.”
Read MorePharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
